{"id":100826,"date":"2026-08-11T13:03:09","date_gmt":"2026-08-11T11:03:09","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?post_type=resources&p=100826"},"modified":"2026-08-11T10:01:46","modified_gmt":"2026-08-11T08:01:46","slug":"veeva-vault-crm-selected-by-eli-lilly-and-company","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/eu\/resources\/veeva-vault-crm-selected-by-eli-lilly-and-company\/","title":{"rendered":"³Ô¹Ï±¬ÁÏ Vault CRM Selected by Eli Lilly and Company"},"content":{"rendered":"

\nPLEASANTON, CA \u2014 August 11, 2026 \u2014 <\/strong> ³Ô¹Ï±¬ÁÏ Systems<\/a> (NYSE: VEEV) today announced that Eli Lilly and Company (Lilly) has committed to ³Ô¹Ï±¬ÁÏ Vault CRM<\/a> globally.<\/p>\n

\nVault CRM is part of the Vault CRM Suite of applications that provides the technology foundation for agentic commercial, the new commercial model that leverages AI to get the right medicines to more patients.\n<\/p>\n

\n\u201cWe are excited to expand our strategic work with ³Ô¹Ï±¬ÁÏ by moving to Vault CRM,\u201d said Giuseppe Firenze, senior vice president, U.S. HCP and field engagement hub at Lilly. \u201cVault CRM will help Lilly bring our breakthrough medicines to more patients.\u201d\n<\/p>\n

\n\u201cLilly creates medicines that make life better for people around the world,\u201d said ³Ô¹Ï±¬ÁÏ CEO Peter Gassner. \u201cWe are proud to expand our strategic work with Lilly as they roll out Vault CRM globally.\u201d\n<\/p>\n

\nLearn more about ³Ô¹Ï±¬ÁÏ Vault CRM Suite, including the Agentic Call Report<\/a> to generate Commercial Evidence, at veeva.com\/eu\/crm<\/a>.<\/p>\n

\nAbout ³Ô¹Ï±¬ÁÏ Systems<\/strong>
\n³Ô¹Ï±¬ÁÏ delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,500 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation<\/a>, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit <\/a>veeva.com\/eu.\n<\/p>\n

\n³Ô¹Ï±¬ÁÏ Forward-Looking Statements<\/strong>
\nThis release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the fiscal year ended April 30, 2026, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.\n<\/p>\n<\/p>\n

###<\/center><\/p>\n

\nContact:<\/strong>\n<\/p>\n

\nMeera Lakhani-Patel
\n³Ô¹Ï±¬ÁÏ Systems, Europe
\nmeera.lakhani-patel@veeva.com<\/a>\n<\/p>\n

\nMaria Scurry
\n³Ô¹Ï±¬ÁÏ Systems
\nmaria.scurry@veeva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Eli Lilly and Company commits to ³Ô¹Ï±¬ÁÏ Vault CRM globally to help bring breakthrough medicines to more patients.<\/p>\n","protected":false},"featured_media":100972,"parent":0,"template":"","class_list":["post-100826","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-area-20-commercial","resource-product-20-crm","resource-type-news-press-release","resource-type-press-release"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t